Upjohn Institute working paper ; 14-203
We evaluate the effects of state-provided financial incentives for biotech companies, which are part of a growing trend of placed-based policies designed to spur innovation clusters. We estimate that the adoption of subsidies for biotech employers by a state raises the number of star biotech scientists in that state by about 15 percent over a three-year period. A 10 percent decline in the user cost of capital induced by an increase in R&D tax incentives raises the number of stars by 22 percent. Most of the gains are due to the relocation of star scientists to adopting states, with limited effect on the productivity of incumbent scientists already in the state. The gains are concentrated among private sector inventors. We uncover little effect of subsidies on academic researchers, consistent with the fact that their incentives are unaffected. Our estimates indicate that the effect on overall employment in the biotech sector is of comparable magnitude to that of star scientists. Consistent with a model where workers are fairly mobile across states, we find limited effects on salaries in the industry. We uncover large effects on employment in the nontraded sector due to a sizable multiplier effect, with the largest impact on employment in construction and retail. Finally, we find mixed evidence of a displacement effect on states that are geographically close, or states that are economically close as measured by migration flows.
ECONOMIC DEVELOPMENT; Industry studies; Entrepreneurship and innovation; Regional policy and planning; Business and tax incentives
Get in touch with the expert
Want to arrange to discuss this work with the author(s)? Contact our .
Moretti, Enrico and Daniel J. Wilson. 2014. "State Incentives for Innovation, Star Scientists, and Jobs: Evidence from Biotech." Upjohn Institute Working Paper 14-203. Kalamazoo, MI: W.E. Upjohn Institute for Employment Research. https://doi.org/10.17848/wp14-203